ARPA-H announces program to develop and deploy AI tools for cardiovascular disease management 

Jan 15, 2026 - 02:50 PM
Two scientists looking at digital health info artificial intelligence

The Advanced Research Projects Agency for Health Jan. 13 announced a program to develop and implement artificial intelligence tools for cardiovascular disease management. The Agentic AI-EnableD CardioVascular CAre TransfOrmation program, referred to as ADVOCATE, seeks to use AI to connect to patient records, assist in scheduling appointments, provide diet and physical therapy recommendations, and write and modify prescriptions, among other services. ARPA-H said a “supervisory agent” would also be developed under the program to support surveillance of clinical AI agents in providing safe and effective recommendations to patients. The ADVOCATE program intends to advance the AI action plan issued by the White House in July 2025.  

ARPA-H said it is accepting proposals for the program across three technical areas: developing a patient-facing AI agent, developing a supervisory agent to ensure continued accuracy and safety of patient-facing agents, and recruiting health systems that will engage in and provide resources for the design and development of technologies and deploy them in their clinical settings. Additional details were included in a solicitation notice. Solution summaries are due Feb. 27 and full proposals are due April 1.

Related News Articles

Headline
Fact sheet details why use of AI alleviates burden for providers and does not improperly increase coding intensity 
The AHA has released a fact sheet explaining how artificial intelligence tools help alleviate administrative burden for providers, particularly in areas such…
Headline
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices
The Food and Drug Administration is seeking public feedback on a discussion paper released today on potential regulatory approaches for generative artificial…
Headline
AHA responds to FDA RFI on health and safety benefits regarding non-device software
The AHA Aug. 13 responded to a Food and Drug Administration request for input on the risks and benefits to health and safety associated with non-device…
Headline
Common Health Coalition receives funding from OpenAI Foundation for new initiative
The Common Health Coalition announced Aug. 13 that it will receive $100 million in funding from the OpenAI Foundation for a new initiative using artificial…
Headline
AONL webinar to explore ambient nursing documentation
The AHA’s American Organization for Nursing Leadership will host a webinar Aug. 5 at noon ET on how nurse leaders can guide ambient documentation from pilot…
Headline
AHA podcast: How Boards Should Engage in AI Decision-making
In this conversation, Ajay Gupta, board vice chair for Trinity Health Mid-Atlantic, explains how trustees can confidently guide artificial intelligence…